日本牙科移植骨替代物市场：市场规模、份额和趋势分析（2025-2031）

2024 年日本牙科移植骨替代物(DBGS) 和其他生医材料市场价值约为 4,800 万美元，预计到 2031 年将成长至近 7,100 万美元。

本报告涵盖牙科骨移植片、牙齿屏障膜、局部抗菌治疗和牙软组织伤口护理—统称为牙科生医材料市场。报告量化了销售量、平均售价 (ASP)、市场价值、成长率和企业市场占有率。此外，报告还深入分析了市场驱动因素和限制因素、併购活动、技术趋势和竞争策略。报告提供了截至 2021 年的历史数据和截至 2031 年的预测数据。

本研究详细阐述了日本口腔保健体系和植入界如何影响再生牙科材料的使用。需求成长的驱动因素包括：人工植牙手术的恢復、患者意识的提高，以及合成和异种移植生医材料的进步，这些材料能够支持可预测的骨整合和美学效果。

市场概览

日本牙科生医材料市场正处于稳定成长阶段，临床应用范围不仅扩展到大学和医院，也扩展到一般牙科诊所。人们对植入成功率和修復体持久性的期望不断提高，植入植入与骨再生手术之间的关联也日益紧密。

• 目前，合成移植材料是日本牙科生医材料的主流。与异质骨移植相比，这些材料因其安全性高、易于取得且文化接受度更高而备受青睐。特别是，牛源性异质骨移植因其已证实的骨传导能力和临床疗效，正逐渐占据市场份额。

异质骨移植的兴起既反映了技术的进步，也体现了像盖斯特利希（Geistlich）这样的全球领先企业的影响力。盖斯特利希凭藉其Bio-Oss®系列产品，持续引领移植材料性能的标竿。儘管人们对动物源性材料仍存在一些文化上的顾虑，但随着教育计画更加重视临床数据和安全保障，临床医师的信心正在增强。

同时，日本牙科市场仍受到严格监管，进口商进口新型再生材料需要漫长的核准流程，减缓了竞争进入市场的速度。儘管如此，随着植入市场逐渐摆脱先前的低迷形象，以及牙科旅游业的蓬勃发展，国内外製造商都在加大对日本生医材料领域的投资。

总体而言，儘管销量保持稳定成长，但市场价值成长预计将来自适度的平均售价成长、不断扩大的产品种类以及每次植入利用率的提高。

市场驱动因素

人工植牙手术的成长

在日本，由于个别事件和有关病人安全的负面报道，人工植牙曾一度停滞数年，但如今正在復苏。植入手术的数量再次增加，尤其是在寻求固定修復方案而非活动假牙的老年人群中。每植入植入，都需要进行植骨手术，因此符合植骨手术条件的患者人数也稳定成长。

随着植入在全科诊所和小型诊所的普及，人工牙根和异质骨移植都将受益。植入前增强骨强度对于成功的骨整合至关重要，人们对这项需求的认识也不断提高。

提高消费者和从业人员的意识

在日本，教育计画和牙科会议越来越重视再生牙科。製造商举办实务培训课程，示范移植材料和屏障膜如何提高植入的长期稳定性。透过参与此类培训，临床医生可以熟悉产品操作、灭菌标准和生物学特性，从而在使用异质骨移植和人工牙根时更加自信。

消费者的意识也在不断提高。如今，选择植入治疗的患者期望骨骼和组织再生能够成为综合治疗方案的一部分。这种以患者主导的需求正在推动高端材料的应用和市场接受度。

技术进步和产品多样性

日本牙科生医材料市场正受益于持续的产品创新。对疾病传播的担忧促使製造商开发先进的合成替代品，并加强同种异体移植材料的灭菌方法。改进的伽马射线辐照和组织处理技术显着降低了风险认知，从而提高了产品品质的稳定性并延长了保质期。

製造商们也不断优化屏障膜，以方便操作并缩短手术时间。例如，Geistlich公司的Bioguide Perio膜改进了表面结构，简化了操作，提高了手术精度。日本国内企业，如GC株式会社，透过其合成碳酸盐磷灰石基Cytrans®颗粒的类似创新，凸显了日本在合成骨生医材料领域的领先地位。

这些产品进步有助于提高平均售价，增强品牌差异化，并抵御来自经销商和公共采购的价格压力。

市场限制

严格的法规环境

日本对医用和牙科生医材料的法律规范是世界上最严格的之一。企业必须在国内进行漫长的临床试验，产品才能註册。这延缓了新生医材料的上市，并增加了国内外供应商的成本。产品供应有限，减少了临床医师的选择，也降低了短期内的市场竞争。

口腔健康状况改善

日本全国范围内的牙科预防倡议改善了各地的口腔健康指标。这一趋势在惠及患者的同时，也减少了对大量修復性治疗的需求。随着拔牙和骨质流失发生率的下降，牙齿移植候选人数的成长速度可能低于人口老化所带来的预期。

文化上对异种移植的反对

儘管牛和猪源移植材料在全球范围内占据主导地位，但由于文化和宗教方面的敏感性，异质骨移植在日本尚未被广泛接受。虽然像盖斯特利希（Geistlich）这样的欧洲製造商在过去几年中取得了稳步进展，但部分患者和医生的抵触情绪仍然限制了异质骨移植领域的发展潜力，尤其是在屏障膜市场，动物源性胶原蛋白仍然是该领域的标准。

国内偷窃资源有限

由于运作的骨库数量有限，日本国内的异体移植骨供应不足。因此，大部分骨移植骨需要从韩国和美国进口。高度的进口依赖，加上监管壁垒，导致价格居高不下，并限制了国内竞争。

整体而言，供应限制和监管摩擦仍然是加速市场成长的关键结构性挑战。

目标市场和数据范围

• 量化指标：市场规模、市占率、预测、成长率、销售量、平均售价。
• 定性内容：成长趋势、市场限制、竞争分析、主要企业的 SWOT 分析、併购、公司组合、颠覆性技术、相关疾病概述。
• 週期：基准年 2024 年，预测期间 2025-2031 年，历史资料 2021-2023 年。
• 资料来源：对日本牙科行业领导者的初步调查、政府和监管文件、私人医院资料、进出口资料、iData Research 的专有资料库。
• 方法说明：收入以临床使用率资料和经销商输入的检验单位数×平均售价计算。

治疗场所包括日本各地的牙医医院、大学诊所和私人牙科诊所。

目标市场及区隔

牙科移植骨替代物（DBGS）市场

• 用途包括齿槽窝保存、上颚窦加强、齿槽嵴加强和牙周病治疗。
• 依材料类型：同种异体移植、异质骨移植和合成材料。

牙科屏障膜市场

• 依类型：可吸收、不可吸收。
• 依材料分类：异种移植、合成。

抗菌牙周治疗市场

含有用于治疗牙周感染疾病和促进再生癒合的局部抗菌剂。

牙科软组织伤口护理市场

• 按类型：塞子、胶带、泡棉。

仅对单元层面的细分市场进行分析。

对每个细分市场进行全面分析，涵盖市场价值、平均售价、销售量和预测成长率。

竞争分析

日本牙科生医材料市场的竞争格局正在发生变化，国内外参与企业都在争夺临床市场份额。

2024年，盖斯特利希製药公司（Geistlich Pharma AG）超越长期占据市场领先地位的国内企业GC株式会社，成为市场领导。盖斯特利希的成功得益于其强大的异质骨移植产品组合，其中以Bio-Oss®和Bio-Oss®胶原蛋白为核心，这两款产品是全球骨再生领域的黄金标准。公司透过持续创新，巩固了其在私人公司和机构牙科领域的市场地位，例如推出了一款50毫克规格的胶原蛋白产品，用于修復小缺损和进行轻微加固。

总部位于东京的GC株式会社排名第二。该公司优势在于其合成DBGS产品和再生系统，这些产品符合日本对非动物源材料的偏好。其合成碳酸盐磷灰石基Cytrans®骨移植材料是全球首创，展现了GC在材料科学领域的领先地位。此外，该公司还将移植材料与植入和CAD/CAM解决方案相结合，以支援完整的数位化牙科工作流程。

Envista Holdings Corporation 凭藉其在 2022 年对 Osteogenics Biomedical、Allotech 和 OBI Biologics 的收购，成为第三大竞争对手。这些收购扩大了该公司在牙科生医材料的市场份额，尤其是在不可吸收膜领域。 Gore 公司 PTFE 膜产品退出亚太市场进一步拓展了 Envista 在日本的业务机会。

整体而言，竞争程度适中，但技术水准很高，市场占有率集中在少数几家跨国公司和国内公司手中，这促使企业持续投资于培训、数位参与和研究合作。

技术与实务的趋势

• 合成优势逐渐显现，异种移植也逐渐被采用：随着临床医生优先考虑临床结果和操作特性，异质骨移植正在获得越来越多的市场份额。
• 先进的灭菌和组织处理：伽马射线照射和增强的纯化方法提高了材料的安全性和储存稳定性。
• 综合再生系统：越来越多的製造商将包括骨移植、屏障膜和软组织产品在内的再生解决方案捆绑在一起，以简化采购和病例计划。
• 数位化植入规划：CAD/CAM 和 3D 列印工作流程可实现更精确的植入体轮廓和客製化膜，从而支援微创技术。
• 教育意义：植入和再生牙科的研究生培训不断扩大，加速了实证生医材料的采用。
• 永续性和在地采购：日本诊所和经销商正在寻求国内采购和环保包装，以满足新的采购标准。

这些因素共同造就了日本，使其成为牙科生医材料领域技术最先进、文化最丰富的市场之一。

地区

本报告重点关注日本。

本报告的目的

日本牙科骨移植片和生医材料市场中成长最快的机会是什么？

异质骨移植、同种移植和合成材料在临床上如何竞争？

日本严格的监管体系下，新产品进入市场的障碍是什么？供应商如何克服这些障碍？

异质骨移植、膜和软组织再生领域的关键参与者有哪些？

灭菌和加工技术的改进将如何影响产品差异化和定价？

成长面临的风险有哪些？例如，人们对动物源性材料的文化抗拒以及口腔卫生状况的改善？

当地企业如何调整其培训计划和行销策略，以适应不断变化的患者和临床医生的态度？

未来五年，日本的再生牙科将如何发展？其市场价值又将如何形塑？

iData Research 的《日本牙科骨移植片及其他生医材料市场报告》透过基于流程的模型、企业市场占有率分析和定价数据来回答这些问题，以帮助您量化日本对牙科再生解决方案的需求，规划您的产品发布，并製定您的定价和分销策略。

目录

图表清单

图表列表

调查方法

全球关税的影响

日本牙科移植骨替代物及其他生医材料市场

• 执行摘要
  • 日本牙科移植骨替代物及其他生医材料市场概览
  • 竞争分析
  • 市场趋势
  • 流程分段
  • 市场区隔
• 介绍
  • 牙科骨移植替代物
  • 牙科屏障膜
  • 局部抗菌牙周治疗
• 手术次数
  • 齿槽骨移植手术
• 计数分析
  • 按手术类型分類的牙科骨移植替代材料销售情况
  • 牙科屏障膜单元（按尺寸）
• 外汇
• 市场概览
• 市场分析与预测
  • 牙科骨移植替代物市场
  • 牙科屏障膜市场
  • 抗菌牙周病治疗市场
  • 牙科软组织创伤护理市场
• 驾驶员和约束装置
• 竞争市占率分析
  • 牙科骨移植替代材料市场竞争格局分析
  • 牙科屏障膜市场竞争格局及市场占有率分析
  • 抗菌牙周治疗市场竞争市占率分析

简称

The Japanese dental bone graft substitute (DBGS) and other biomaterials market was valued at nearly $48 million in 2024. It is projected to grow to reach almost $71 million by 2031.

This report covers dental bone graft substitutes, dental barrier membranes, local antimicrobial periodontal treatments, and dental soft tissue wound care-collectively referred to as the dental biomaterials market. It quantifies units sold, average selling prices (ASPs), market values, growth rates, and company shares, while providing in-depth analysis of market drivers and limiters, mergers and acquisitions, technology trends, and competitive strategies. The report includes historical data to 2021 and forecasts to 2031.

The study provides a detailed view of how Japan's oral health system and its implantology community are influencing regenerative dental material usage. Demand is driven by the recovery of dental implant procedures, growing patient awareness, and advances in synthetic and xenograft biomaterials that support predictable osseointegration and aesthetic outcomes.

Market Overview

The Japanese dental biomaterials market is in a steady growth phase as clinical adoption broadens beyond university and hospital settings into general dental practices. Rising expectations for implant success rates and longer-lasting restorations have strengthened the link between implant placement and bone regeneration procedures.

• Synthetic grafts currently dominate Japan's dental biomaterials landscape. These materials are favored for their safety profile, availability, and cultural acceptance compared to xenografts. However, the market has begun shifting: xenograft products, particularly those of bovine origin, are gradually capturing share due to their proven osteoconductive performance and clinical outcomes.

The shift toward xenografts reflects both technological advancements and the influence of global leaders like Geistlich, whose Bio-Oss(R) series continues to set the benchmark for graft performance. Despite lingering cultural hesitation toward animal-derived materials, clinician confidence is increasing as educational programs emphasize clinical data and safety assurance.

At the same time, Japan's dental market remains tightly regulated. Importers face lengthy approval timelines for new regenerative materials, which slows competitive entry. Nonetheless, as the implant market rebounds from earlier negative publicity and dental tourism strengthens, local and international manufacturers are re-investing in the Japanese biomaterials segment.

Overall, market value growth is expected to come from moderate ASP increases, expanded product variety, and higher utilization per implant procedure, even as unit volume growth remains stable.

Market Drivers

Growth of Dental Implant Procedures

Dental implant adoption in Japan has recovered after several years of stagnation caused by isolated patient safety incidents and negative media coverage. Implant surgery volumes are rising again, particularly among aging adults who seek fixed prosthetic solutions over removable dentures. Each implant placement increases the likelihood of a grafting procedure, creating a steady pool of patients eligible for DBGS use.

As implant penetration expands across general practices and smaller clinics, both synthetic and xenograft materials benefit. Bone quality enhancement prior to implant placement remains critical for successful osseointegration, and awareness of this requirement continues to grow.

Growing Consumer and Practitioner Awareness

Educational programs and dental conferences in Japan increasingly highlight regenerative dentistry. Manufacturers sponsor hands-on training that demonstrates how grafting materials and barrier membranes improve long-term implant stability. With this exposure, clinicians gain familiarity with product handling, sterilization standards, and biologic behavior, resulting in stronger confidence in using xenograft and synthetic options alike.

Consumer awareness is also increasing. Patients who invest in implant therapy now expect bone and tissue regeneration to be part of a comprehensive treatment plan. This patient-driven demand reinforces material adoption and premium product acceptance.

Technological Improvements and Product Variety

The Japanese dental biomaterials market benefits from continuous product innovation. Concerns about disease transmission have pushed manufacturers to develop advanced synthetic alternatives and to enhance allograft sterilization methods. The use of gamma irradiation and improved tissue processing has substantially reduced risk perception, enabling more consistent quality and longer shelf life.

Manufacturers are also optimizing barrier membranes for easier handling and reduced chair time. Geistlich's Bio-Gide(R) Perio, for example, was engineered with a modified surface structure to simplify manipulation and enhance accuracy during surgery. Similar innovation trends among domestic companies like GC Corporation-through its Cytrans(R) granules based on synthetic carbonate apatite-highlight Japan's leading role in synthetic bone biomaterials.

These product advancements support higher ASPs and strengthen brand differentiation, providing a buffer against pricing pressures from distributors and public procurement.

Market Limiters

Strict Regulatory Environment

Japan's regulatory framework for medical and dental biomaterials is among the most stringent globally. Companies must conduct lengthy domestic clinical trials before receiving product registration. This slows the introduction of new biomaterials and raises costs for both local and foreign suppliers. Limited product availability constrains choice for clinicians and dampens short-term competitive activity.

Improving Oral Health Outcomes

Nationwide preventive dentistry initiatives have improved oral health indicators across Japan. While this trend benefits patients, it reduces the need for extensive restorative procedures. As fewer extractions and bone defects occur, the total pool of grafting candidates may grow more slowly than the aging population would otherwise suggest.

Cultural Disapproval of Xenografts

Despite global dominance of bovine and porcine grafts, xenograft acceptance in Japan remains tempered by cultural and religious sensitivities. Although Geistlich and other European manufacturers have seen steady adoption in recent years, resistance from some patients and practitioners continues to limit the potential expansion of the xenograft segment-particularly in the barrier membrane market, where animal-derived collagen is standard.

Limited Supply of Domestic Allografts

Japan maintains only a few operational bone banks, restricting the availability of locally sourced allograft material. As a result, much of the supply is imported from South Korea and the United States. High import dependency and regulatory barriers combine to sustain premium prices and limit domestic competition.

Overall, supply constraints and regulatory friction remain the key structural challenges to faster market growth.

Market Coverage and Data Scope

• Quantitative coverage: Market size, market shares, forecasts, growth rates, units sold, and average selling prices.
• Qualitative coverage: Growth trends, market limiters, competitive analysis, SWOT profiles of leading players, mergers and acquisitions, company portfolios, disruptive technologies, and related disease overviews.
• Time frame: Base year 2024; forecasts 2025 to 2031; historical data 2021 to 2023.
• Data sources: Primary interviews with Japanese dental industry leaders, government and regulatory filings, private hospital data, import/export data, and iData Research's proprietary database.
• Method note: Revenue is calculated as units X ASP, validated through clinical utilization data and distributor input.

Care settings include dental hospitals, university clinics, and private dental practices across Japan.

Markets Covered and Segmentation

Dental Bone Graft Substitute (DBGS) Market

• By application: Socket preservation, sinus augmentation, ridge augmentation, periodontal.
• By material type: Allograft, xenograft, synthetic.

Dental Barrier Membrane Market

• By type: Resorbable, non-resorbable.
• By material: Xenograft, synthetic.

Antimicrobial Periodontal Treatment Market

Includes local antimicrobial agents used to manage periodontal infections and support regenerative healing.

Dental Soft Tissue Wound Care Market

• By type: Plugs, tape, foam.

Segment analyzed at the unit level only.

Each subsegment is analyzed with full coverage of market values, ASPs, units, and forecast growth.

Competitive Analysis

The competitive landscape in Japan's dental biomaterials market is evolving as both domestic and global players vie for clinical mindshare.

Geistlich Pharma AG emerged as the market leader in 2024, overtaking long-time domestic leader GC Corporation. Geistlich's success is anchored in its strong xenograft portfolio, led by Bio-Oss(R) and Bio-Oss(R) Collagen, considered the global gold standard for bone regeneration. The company's continuous innovation, including the 50 mg collagen variant for narrow defects and minor augmentations, has strengthened its position across both private and institutional dental sectors.

GC Corporation, headquartered in Tokyo, ranked second overall. Its strength lies in synthetic DBGS products and regenerative systems that align with Japan's preference for non-animal materials. The Cytrans(R) bone graft-based on synthetic carbonate apatite-is the first of its kind globally and demonstrates GC's leadership in material science. The company also integrates grafting materials with its implant and CAD/CAM solutions, supporting full digital dentistry workflows.

Envista Holdings Corporation became the third-largest competitor through its 2022 acquisition of Osteogenics Biomedical, Allotech, and OBI Biologics. This acquisition expanded its presence in dental biomaterials, particularly within the non-resorbable membrane category, a segment where Osteogenics had previously held a strong position. The withdrawal of Gore's PTFE membrane products from the Asia-Pacific market has further enhanced Envista's opportunity in Japan.

Overall, competition is moderate but technically sophisticated. Market share is concentrated among a few multinational and domestic players, encouraging continued investment in training, digital engagement, and research collaborations.

Technology and Practice Trends

• Synthetic dominance with gradual xenograft adoption: While synthetics remain the majority, xenografts are gaining share as clinicians prioritize clinical outcomes and handling characteristics.
• Advanced sterilization and tissue processing: Gamma irradiation and enhanced purification methods are improving material safety and shelf stability.
• Integrated regenerative systems: Manufacturers increasingly offer bundled regenerative solutions that include bone grafts, barrier membranes, and soft tissue products to simplify procurement and case planning.
• Digital implant planning: CAD/CAM and 3D printing workflows enable more precise graft contouring and custom membranes, supporting minimally invasive techniques.
• Educational influence: Post-graduate training in implantology and regenerative dentistry continues to expand, accelerating adoption of evidence-based biomaterials.
• Sustainability and local sourcing: Japanese clinics and distributors are exploring domestic sourcing and environmentally responsible packaging to meet new procurement standards.

These factors combine to make Japan one of the most technically progressive yet culturally nuanced markets for dental biomaterials globally.

Geography

This edition covers Japan.

Why This Report

Where is the fastest-growing opportunity within Japan's dental bone graft substitute and biomaterials market?

How are xenograft, allograft, and synthetic materials competing within clinical practice?

What are the barriers to new product entry under Japan's strict regulatory system, and how can suppliers navigate them?

Which companies are positioned to lead in xenografts, membranes, and soft tissue regeneration segments?

How do improvements in sterilization and processing technology affect product differentiation and pricing?

What are the risks to growth, including cultural resistance to animal-derived materials and improving oral health outcomes?

How can local and multinational companies align training programs and marketing with evolving patient and clinician awareness?

Where will regenerative dentistry in Japan evolve over the next five years, and how will this shape market value?

The Japan Dental Bone Graft Substitute and Other Biomaterials Market Report by iData Research answers these questions with procedure-aware models, company share analysis, and pricing data. Use it to quantify demand, plan product launches, and set pricing and distribution strategies for regenerative dental solutions in Japan.

TABLE OF CONTENT

Table Of Contents

List Of Figures

List Of Charts

Research Methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems And Perform Secondary Research
• Step 3: Preparation For Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast And Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review And Market Release
• Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Japan Dental Bone Graft Substitute and Other Biomaterials Market

• 5.1 Executive Summary
  • 5.1.1 Japan Dental Bone Graft Substitute and Other Biomaterials Market Overview
  • 5.1.2 Competitive Analysis
  • 5.1.3 Market Trends
  • 5.1.4 Procedure Segmentation
  • 5.1.5 Market Segmentation
• 5.2 Introduction
  • 5.2.1 Dental Bone Graft Substitutes
    • 5.2.1.1 Autografts
    • 5.2.1.2 Allografts
    • 5.2.1.2.1 Mineralized Allografts
    • 5.2.1.2.2 Demineralized Bone Matrix
    • 5.2.1.3 Xenografts
    • 5.2.1.4 Synthetics
  • 5.2.2 Dental Barrier Membranes
  • 5.2.3 Local Antimicrobial Periodontal Treatment
• 5.3 Procedure Numbers
  • 5.3.1 Dental Bone Grafting Procedures
• 5.4 Unit Analysis
  • 5.4.1 Dental Bone Graft Substitute Units Sold by Procedure Type
  • 5.4.2 Dental Barrier Membrane Units Sold by Size
    • 5.4.2.1 Resorbable Dental Barrier Membrane Units Sold by Size
    • 5.4.2.2 Non-Resorbable Dental Barrier Membrane Units Sold by Size
• 5.5 Currency Exchange Rate
• 5.6 Market Overview
• 5.7 Market Analysis and Forecast
  • 5.7.1 Dental Bone Graft Substitute Market
    • 5.7.1.1 Allograft Market
    • 5.7.1.2 Xenograft Market
    • 5.7.1.3 Synthetic Market
  • 5.7.2 Dental Barrier Membrane Market
    • 5.7.2.1 Dental Barrier Membrane Market by Segment
    • 5.7.2.1.1 Xenograft Dental Barrier Membrane Market
    • 5.7.2.1.2 Synthetic Dental Barrier Membrane Market
    • 5.7.2.2 Dental Barrier Membrane Market by Material
    • 5.7.2.2.1 Resorbable Dental Barrier Membrane Market
    • 5.7.2.2.2 Non-Resorbable Dental Barrier Membrane Market
  • 5.7.3 Antimicrobial Periodontal Treatment Market
  • 5.7.4 Dental Soft Tissue Wound Care Market
    • 5.7.4.1 Dental Wound Care Plugs Market
    • 5.7.4.2 Dental Wound Care Tape Market
    • 5.7.4.3 Dental Wound Care Foam Market
• 5.8 Drivers and Limiters
  • 5.8.1 Market Drivers
  • 5.8.2 Market Limiters
• 5.9 Competitive Market Share Analysis
  • 5.9.1 Dental Bone Graft Substitute Market Competitive Market Share Analysis
  • 5.9.2 Dental Barrier Membrane Market Competitive Market Share Analysis
  • 5.9.3 Antimicrobial Periodontal Treatment Market Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

• Chart 5-1: Dental Bone Graft Substitute and Other Biomaterials by Segment, Japan, 2024
• Chart 5-2: Dental Bone Graft Substitute and Other Biomaterials Market Overview, Japan, 2024 & 2031
• Chart 5-3: Dental Bone Grafting Procedures by Segment, Japan, 2021-2031
• Chart 5-4: Dental Bone Graft Substitute and Other Biomaterials Market by Segment, Japan, 2021-2031
• Chart 5-5: Leading Competitors, Dental Bone Graft Substitute and Other Biomaterials Market, Japan, 2024

LIST OF FIGURES

• Figure 5-1: Dental Bone Graft Substitute and Other Biomaterials Market Share Ranking by Segment, Japan, 2024
• Figure 5-2: Factors Impacting the Dental Bone Graft Substitute and Other Biomaterials Market by Segment, Japan
• Figure 5-3: Dental Bone Graft Substitute and Other Biomaterials Procedure Segmentation, Japan
• Figure 5-4: Dental Bone Graft Substitute and Other Biomaterials Market Segmentation, Japan
• Figure 5-5: Dental Bone Grafting Procedures and Penetration Rates by Segment, Japan, 2021-2031
• Figure 5-6: Dental Bone Graft Procedure Numbers and Volume Usage by Application, Japan, 2021-2031 (1 of 2)
• Figure 5-7: Dental Bone Graft Procedure Numbers and Volume Usage by Application, Japan, 2021-2031 (2 of 2)
• Figure 5-8: Dental Bone Graft Units Sold by Procedure, Japan, 2021-2031
• Figure 5-9: Resorbable Dental Barrier Membrane Units Sold by Size, Japan, 2021-2031
• Figure 5-10: Non-Resorbable Dental Barrier Membrane Units Sold by Size, Japan, 2021-2031
• Figure 5-11: Currency Exchange Rate, 2024
• Figure 5-12: Dental Bone Graft Substitute and Other Biomaterials Market by Segment, Japan, 2021-2031 (US$M)
• Figure 5-13: Dental Bone Graft Substitute and Other Biomaterials Market by Segment, Japan, 2021-2031 (JP¥M)
• Figure 5-14: Total Dental Bone Graft Substitute Market, Japan, 2021-2031
• Figure 5-15: Dental Bone Graft Substitute Market by Segment, Japan, 2021-2031 (US$M)
• Figure 5-16: Dental Bone Graft Substitute Market by Segment, Japan, 2021-2031 (JP¥M)
• Figure 5-17: Xenograft Market, Japan, 2021-2031
• Figure 5-18: Synthetic Market, Japan, 2021-2031
• Figure 5-19: Total Dental Barrier Membrane Market, Japan, 2021-2031
• Figure 5-20: Dental Barrier Membrane Market by Segment, Japan, 2021-2031 (US$M)
• Figure 5-21: Dental Barrier Membrane Market by Segment, Japan, 2021-2031 (JP¥M)
• Figure 5-22: Xenograft Dental Barrier Membrane Market, Japan, 2021-2031
• Figure 5-23: Bovine Xenograft Dental Barrier Membrane Market, Japan, 2021-2031
• Figure 5-24: Porcine Xenograft Dental Barrier Membrane Market, Japan, 2021-2031
• Figure 5-25: Synthetic Dental Barrier Membrane Market, Japan, 2021-2031
• Figure 5-26: Dental Barrier Membrane Market by Material, Japan, 2021-2031 (US$M)
• Figure 5-27: Dental Barrier Membrane Market by Material, Japan, 2021-2031 (JP¥M)
• Figure 5-28: Resorbable Dental Barrier Membrane Market, Japan, 2021-2031
• Figure 5-29: Non-Resorbable Dental Barrier Membrane Market, Japan, 2021-2031
• Figure 5-30: Non-Reinforced Non-Resorbable Dental Barrier Membrane Market, Japan, 2021-2031
• Figure 5-31: Titanium-Reinforced Non-Resorbable Dental Barrier Membrane Market, Japan, 2021-2031
• Figure 5-32: Total Antimicrobial Periodontal Treatment Market, Japan, 2021-2031
• Figure 5-33: Dental Wound Care Market by Type, Japan, 2021-2031 (US$M)
• Figure 5-34: Dental Wound Care Market by Type, Japan, 2021-2031 (JP¥M)
• Figure 5-35: Dental Soft Tissue Wound Care Market, Japan, 2021-2031
• Figure 5-36: Dental Wound Care Plugs Market, Japan, 2021-2031
• Figure 5-37: Dental Wound Care Tape Market, Japan, 2021-2031
• Figure 5-38: Dental Wound Care Foam Market, Japan, 2021-2031
• Figure 5-39: Leading Competitors, Dental Bone Graft Substitute and Other Biomaterials Market, Japan, 2024
• Figure 5-40: Leading Competitors, Dental Bone Graft Substitute Market, Japan, 2024
• Figure 5-41: Leading Competitors, Dental Barrier Membrane Market, Japan, 2024
• Figure 5-42: Leading Competitors, Antimicrobial Periodontal Treatment Market, Japan, 2024